Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to conduct survey-based assessments for the safety of air travel in patients with Birt-Hogg-Dube syndrome (BHD). The study will enroll patients through the clinic network at Rare Lung Disease Consortium (RLDC) and through the BHD foundation website. Patients will have access to the questionnaire via REDCap (an online data management system) and each patient will be provided with a link to complete the survey. The investigators plan on enrolling approximately 100 patients with BHD for the purpose of this study. Secondary aims of this study include further characterization of the clinical aspects of disease and to establish a contact registry for these patients, in order to facilitate future studies.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03040115
Study type Observational [Patient Registry]
Source University of Cincinnati
Contact
Status Completed
Phase
Start date August 2015
Completion date August 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05534854 - Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes
Terminated NCT02504892 - Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer Phase 2
Recruiting NCT03749980 - MyVHL: Patient Natural History Study
Recruiting NCT06330350 - Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
Enrolling by invitation NCT06330324 - Reproductive Options in Inherited Skin Diseases